Vigil Quick Ratio from 2010 to 2024

VIGL Stock  USD 2.40  0.07  2.83%   
Vigil Neuroscience Quick Ratio yearly trend continues to be quite stable with very little volatility. The value of Quick Ratio is projected to decrease to 9.91. Quick Ratio is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. View All Fundamentals
 
Quick Ratio  
First Reported
2010-12-31
Previous Quarter
10.45424921
Current Value
9.91
Quarterly Volatility
1.57008907
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vigil Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vigil Neuroscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 379.1 K, Interest Expense of 85.2 K or Selling General Administrative of 17.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.18. Vigil financial statements analysis is a perfect complement when working with Vigil Neuroscience Valuation or Volatility modules.
  
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.

Latest Vigil Neuroscience's Quick Ratio Growth Pattern

Below is the plot of the Quick Ratio of Vigil Neuroscience over the last few years. It is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. Vigil Neuroscience's Quick Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vigil Neuroscience's overall financial position and show how it may be relating to other accounts over time.
Quick Ratio10 Years Trend
Pretty Stable
   Quick Ratio   
       Timeline  

Vigil Quick Ratio Regression Statistics

Arithmetic Mean12.42
Geometric Mean12.33
Coefficient Of Variation12.64
Mean Deviation0.94
Median12.68
Standard Deviation1.57
Sample Variance2.47
Range6.6873
R-Value(0.25)
Mean Square Error2.49
R-Squared0.06
Significance0.37
Slope(0.09)
Total Sum of Squares34.51

Vigil Quick Ratio History

2024 9.91
2023 10.45
2022 16.55
2021 9.87

About Vigil Neuroscience Financial Statements

Vigil Neuroscience investors utilize fundamental indicators, such as Quick Ratio, to predict how Vigil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Quick Ratio 10.45  9.91 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.40)
Return On Equity
(0.70)
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.